Clinical Trial Update: Imatinib for Multiple Sclerosis (MS) Relapses [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating imatinib for multiple sclerosis relapses is in an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Tomas Olsson | Conditions: Multiple Sclerosis | Phase 2 | Status: UNKNOWN